Universitaetsmedizin Goettingen
Universitaetsmedizin Goettingen is recorded as a service provider in 7 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 7 of 7 trials · Latest update first
Proof-of-Concept Evaluation of Immunological Assays Using Human Blood and Urine Samples after Vaccination with StroVac
Sponsor Strathmann GmbH & Co. KG
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Efficacy of Venetoclax in combination with Rituximab in Waldenström’s Macroglobulinemia
Sponsor University Hospital Of Ulm AöR
- Start (EU)
- Latest update
- Estimated end
- Not reported
Early switch to oral antibiotic therapy in vertebral osteomyelitis: a multicentre, open-label, randomised, active control, parallel group, non-inferiority trial (sWITCH-VO)
Sponsor University Of Cologne
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 2 Theranostic Trial Evaluating the Effects of Thiethylperazine in Patients Diagnosed with an Early Stage of Alzheimer's disease
Sponsor Immungenetics AG
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Multicenter, Phase Ib/IIa Study on the Safety and Efficacy of Autologous Peptide-coupled Red Blood Cells in Patients with Relapsing Remitting Multiple Sclerosis
Sponsor Cellerys AG
- Start (EU)
- Latest update
- Estimated end
Efficacy and safety of Carfilzomib in combination with Ibrutinib vs. Ibrutinib alone in Waldenström’s Macroglobulinemia (CZAR-1)
Sponsor Universitaetsklinikum Ulm AöR
- Start (EU)
- Latest update
- Estimated end
- Not reported
An open-label, prospective Phase III clinical study to compare polatuzumab vedotin plus rituximab, ifosfamide, carboplatin and etoposide (Pola-R-ICE) with rituximab, ifosfamide, carboplatin and etoposide (R-ICE) alone as salvage therapy in patients with primary refractory or relapsed diffuse large B-cell lymphoma (DLBCL)
Sponsor GWT-Tud GmbH
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Universitaetsmedizin Goettingen?
The 2026-10-09 snapshot links Universitaetsmedizin Goettingen to 7 distinct CTIS trials. Recorded services include Data management, Laboratory services, Blood donation unit for site 2- 08/Göttingen/Weber, MRI recording for site 2-08/Göttingen/Weber, among 5 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Universitaetsmedizin Goettingen?
The most frequently recorded therapeutic areas are Infectious Disease, Haematological Malignancies, Musculoskeletal, Urology. Recorded phases include Phase 4, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Universitaetsmedizin Goettingen conducted?
The linked trials record locations in 7 countries, including Germany, Austria, Greece, Czechia, Spain. These are trial locations, not confirmed office locations or countries where Universitaetsmedizin Goettingen delivered services.
What can this page tell me about Universitaetsmedizin Goettingen's trial experience?
Browse 7 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Universitaetsmedizin Goettingen. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Universitaetsmedizin Goettingen